Business Context and Reporting Period
This Form 8-K filing by Genworth Financial, Inc. (NYSE: GNW) reports on events occurring as of December 31, 2023, with the report filed on January 3, 2024. The filing addresses Item 5.02 regarding the departure of a senior officer and the appointment of a successor within the U.S. Life Insurance division.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on executive personnel changes and associated compensation arrangements.
Material Changes
- Departure: Brian K. Haendiges resigned as Executive Vice President—U.S. Life Insurance, effective December 31, 2023. He will remain in an advisory role through April 2024 to facilitate transition.
- Appointment: Jamala M. Arland was appointed Executive Vice President—U.S. Life Insurance, effective January 1, 2024.
- Compensation: Ms. Arland's new role includes an annual base salary of $500,000 and an annual incentive target of 100% of her base salary. She is eligible for the Senior Executive Severance Plan and other standard executive benefits.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or discussion of material risks and contingencies. Management commentary is limited to the professional background of the new appointee, noting her extensive experience in long-term care insurance, actuarial roles, and industry representation.
Investor Verification Checklist
- Verify the transition timeline for the U.S. Life Insurance division through April 2024.
- Review the Definitive Proxy Statement on Schedule 14A (filed April 5, 2023) for details on the Senior Executive Severance Plan and other benefit arrangements.
- Monitor future filings for the appointment of a permanent successor if the advisory role concludes without a further announcement.